Close cardiac surveillance of patients treated with anthracyclines, also necessary after chemotherapy?
Baur
Leo H B
LH
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D001794:Blood Pressure; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000503:physiopathology / Q000556:secondary; D003971:Diastole; D004305:Dose-Response Relationship, Drug; D015251:Epirubicin / Q000009:adverse effects*; D005260:Female; D015637:Gated Blood-Pool Imaging; D006333:Heart Failure / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000503:physiopathology; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D018570:Risk Assessment; D012307:Risk Factors; D013599:Systole; D013997:Time Factors; D016277:Ventricular Function, Left / Q000187:drug effects*
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin